Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.16
-0.10 (-1.38%)
Dec 29, 2025, 3:17 PM EST - Market open
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $650.78 million as of December 29, 2025. Its market cap has decreased by -31.00% in one year.
Market Cap
650.78M
Enterprise Value
595.53M
1-Year Change
-31.00%
Ranking
Category
Stock Price
$7.16
Market Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has increased from $515.41M to $650.78M, an increase of 26.26%. That is a compound annual growth rate of 11.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 659.86M | -36.46% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
| Oct 31, 2023 | 515.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 970.32B |
| Johnson & Johnson | 501.30B |
| AbbVie | 407.97B |
| UnitedHealth Group | 298.45B |
| AstraZeneca | 287.56B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.34B |
| Novo Nordisk | 232.28B |